ONCONOVA THERAPEUTICS INC (ONTX) Stock Cash Flow
NASDAQ:ONTX - Nasdaq - US68232V8019 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.18M | -18.96M | -16.16M | -25.16M | -21.50M | |||
| Depreciation Amortization | 12.00K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Change In Working Capital | 1.48M | 1.48M | -3.59M | 1.49M | -330.00K | |||
| Other non cash items | 1.30M | 1.17M | 260.00K | 580.00K | 990.00K | |||
| OPERATING CASH FLOW | -17.38M | -16.29M | -19.49M | -23.08M | -20.83M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -60.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | -20.00K | -60.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 0.00 | 55.56M | 19.36M | 26.65M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 0.00 | 55.56M | 19.36M | 26.65M | |||
| Exchange Rate Effect | 33.00K | -20.00K | -30.00K | 30.00K | -10.00K | |||
| CHANGE IN CASH | -17.36M | -16.31M | 36.04M | -3.71M | 5.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.38M | -16.29M | -19.49M | -23.08M | -20.83M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -60.00K | |||
| FREE CASH FLOW | -17.40M | -16.29M | -19.49M | -23.10M | -20.89M | |||
All data in USD